Antineoplastic effects of erufosine on Graffi myeloid tumour in hamsters

Cancer has become one of the most significant health challenges for both human and veterinary medicine. The present study examined the antineoplastic and antimetastatic activity of the novel membrane-targeting anticancer agent erufosine. The antitumour effects of erufosine on Graffi virus-induced ex...

Full description

Bibliographic Details
Main Authors: A. Georgieva, R. Toshkova, K. Todorova, R. Tzoneva
Format: Article
Language:English
Published: Faculty of Veterinary Medicine, Trakia University, Stara Zagora, Bulgaria 2021-09-01
Series:Bulgarian Journal of Veterinary Medicine
Subjects:
_version_ 1818922473230434304
author A. Georgieva
R. Toshkova
K. Todorova
R. Tzoneva
author_facet A. Georgieva
R. Toshkova
K. Todorova
R. Tzoneva
author_sort A. Georgieva
collection DOAJ
description Cancer has become one of the most significant health challenges for both human and veterinary medicine. The present study examined the antineoplastic and antimetastatic activity of the novel membrane-targeting anticancer agent erufosine. The antitumour effects of erufosine on Graffi virus-induced experimental myeloid tumour in hamsters was assessed by histopathological methods and evaluation of some biometric parameters of tumour growth. Two schemes of experimental antitumour therapy were applied  one that started simultaneously with the tumour transplantation and a second one that started after the appearance of palpable tumours. The results demonstrated protective antitu-mour effect of erufosine, expressed by decrease of transplantability, tumour growth inhibition, sup-pression of metastatic activity and extension of mean survival time. The effectivity of the experimental therapy was more pronounced when it was started simultaneously with the transplantation of the tumour cells. Presented results suggest that erufosine is a promising drug candidate for treatment of haematological malignances.
first_indexed 2024-12-20T01:54:06Z
format Article
id doaj.art-4fcdcd458d4a41f5a1bfa28ee4fe3611
institution Directory Open Access Journal
issn 1311-1477
1313-3543
language English
last_indexed 2024-12-20T01:54:06Z
publishDate 2021-09-01
publisher Faculty of Veterinary Medicine, Trakia University, Stara Zagora, Bulgaria
record_format Article
series Bulgarian Journal of Veterinary Medicine
spelling doaj.art-4fcdcd458d4a41f5a1bfa28ee4fe36112022-12-21T19:57:32ZengFaculty of Veterinary Medicine, Trakia University, Stara Zagora, BulgariaBulgarian Journal of Veterinary Medicine1311-14771313-35432021-09-0124344244910.15547/bjvm.2278Antineoplastic effects of erufosine on Graffi myeloid tumour in hamstersA. Georgieva0R. Toshkova1K. Todorova2R. Tzoneva3Institute of Experimental Morphology, Pathology and Anthropology with Museum, Bulgarian Academy of Sciences, Sofia, BulgariaInstitute of Experimental Morphology, Pathology and Anthropology with Museum, Bulgarian Academy of Sciences, Sofia, BulgariaInstitute of Experimental Morphology, Pathology and Anthropology with Museum, Bulgarian Academy of Sciences, Sofia, BulgariaInstitute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences, Sofia, BulgariaCancer has become one of the most significant health challenges for both human and veterinary medicine. The present study examined the antineoplastic and antimetastatic activity of the novel membrane-targeting anticancer agent erufosine. The antitumour effects of erufosine on Graffi virus-induced experimental myeloid tumour in hamsters was assessed by histopathological methods and evaluation of some biometric parameters of tumour growth. Two schemes of experimental antitumour therapy were applied  one that started simultaneously with the tumour transplantation and a second one that started after the appearance of palpable tumours. The results demonstrated protective antitu-mour effect of erufosine, expressed by decrease of transplantability, tumour growth inhibition, sup-pression of metastatic activity and extension of mean survival time. The effectivity of the experimental therapy was more pronounced when it was started simultaneously with the transplantation of the tumour cells. Presented results suggest that erufosine is a promising drug candidate for treatment of haematological malignances.alkylphosphocholinesantitumour activityerufosinemyeloid tumour
spellingShingle A. Georgieva
R. Toshkova
K. Todorova
R. Tzoneva
Antineoplastic effects of erufosine on Graffi myeloid tumour in hamsters
Bulgarian Journal of Veterinary Medicine
alkylphosphocholines
antitumour activity
erufosine
myeloid tumour
title Antineoplastic effects of erufosine on Graffi myeloid tumour in hamsters
title_full Antineoplastic effects of erufosine on Graffi myeloid tumour in hamsters
title_fullStr Antineoplastic effects of erufosine on Graffi myeloid tumour in hamsters
title_full_unstemmed Antineoplastic effects of erufosine on Graffi myeloid tumour in hamsters
title_short Antineoplastic effects of erufosine on Graffi myeloid tumour in hamsters
title_sort antineoplastic effects of erufosine on graffi myeloid tumour in hamsters
topic alkylphosphocholines
antitumour activity
erufosine
myeloid tumour
work_keys_str_mv AT ageorgieva antineoplasticeffectsoferufosineongraffimyeloidtumourinhamsters
AT rtoshkova antineoplasticeffectsoferufosineongraffimyeloidtumourinhamsters
AT ktodorova antineoplasticeffectsoferufosineongraffimyeloidtumourinhamsters
AT rtzoneva antineoplasticeffectsoferufosineongraffimyeloidtumourinhamsters